Jazz Pharmaceuticals plc cotiza a 217.05 USD y tiene una capitalización bursátil de $14.1B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Ga…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $5.71 | $6.34 | $6.64 |
| Estimado | $3.89 | $6.18 | $4.66 | $6.51 |
| Sorpresa | — | -7.6% | +36.1% | +2.0% |
| Métrica | JAZZ | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -10.1% | -38.6% | +28.5% |
| Net Margin | -8.3% | -33.6% | +25.2% |
| FCF Margin | 30.4% | -13.9% | +44.3% |
| ROE | -8.3% | -40.4% | +32.1% |
| ROA | -3.0% | -32.0% | +29.0% |
| Current Ratio | 1.86 | 2.84 | -0.98 |
| Debt / Equity | 1.24 | 0.28 | +0.96 |